Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide, Paclitaxel, and Estramustine in Metastatic AI-PCa
NCT00038246Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2000
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in prostate carcinoma, sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2000; status: completed.
02
Drugs
thalidomide
03
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT00038246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038246.